Posts by evereiter201

Because of the multifactorial nature of HSDD, treatment can be complex and must try to target the organic and psychosocial facets of the problem. Bremelanotide is a melanocortin receptor agonist and has been recently authorized by the FDA to treat HSDD. The recommended dose of bremelanotide is 1.75 mg infused subcutaneously in the abdomen or…

Read More